Ann Intern Med. 2005 Sep 6;143(5):355-61.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

Erratum in

Ann Intern Med. 2005 Oct 4;143(7):547.

Abstract

This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility, along with the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, is included in the evidence synthesis available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The recommendation is also posted on the Web site of the National Guideline Clearinghouse (http://www.guideline.gov).

Comment in

Taking family history seriously. [Ann Intern Med. 2005]
Taking family history seriously.Burke W. Ann Intern Med. 2005 Sep 6; 143(5):388-9.
Review: only women with specific family histories should be referred for counseling or evaluation for BRCA breast and ovarian cancer susceptibility testing. [ACP J Club. 2006]
Review: only women with specific family histories should be referred for counseling or evaluation for BRCA breast and ovarian cancer susceptibility testing.Hall MJ, Neugut AI. ACP J Club. 2006 Mar-Apr; 144(2):37.
Genetic risk assessment and BRCA mutation testing. [Ann Intern Med. 2006]
Genetic risk assessment and BRCA mutation testing.Ormond KE, Bellcross C, Weissman S. Ann Intern Med. 2006 Feb 21; 144(4):303-4; discussion 304.

PMID:: 16144894; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Icon for Silverchair Information Systems

Save items

Related citations in PubMed

Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations. [Ann Intern Med. 2005]
Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.
[No authors listed]Ann Intern Med. 2005 Sep 6; 143(5):I47.
Review Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. [Ann Intern Med. 2005]
Review Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
Nelson HD, Huffman LH, Fu R, Harris EL, U.S. Preventive Services Task Force. Ann Intern Med. 2005 Sep 6; 143(5):362-79.
Screening for coronary heart disease: recommendation statement. [Ann Intern Med. 2004]
Screening for coronary heart disease: recommendation statement.
U.S. Preventive Services Task Force. Ann Intern Med. 2004 Apr 6; 140(7):569-72.
Lung cancer screening: recommendation statement. [Ann Intern Med. 2004]
Lung cancer screening: recommendation statement.
U.S. Preventive Services Task Force. Ann Intern Med. 2004 May 4; 140(9):738-9.
Review Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. [Am Fam Physician. 2006]
Review Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
Wolff TA, Wilson JE. Am Fam Physician. 2006 Nov 15; 74(10):1759-60.

See reviews... See all...

Cited by 45 PubMed Central articles

Task force breaks new ground with breast cancer recommendations. [Biotechnol Healthc. 2005]
Task force breaks new ground with breast cancer recommendations.
Carlson B. Biotechnol Healthc. 2005 Dec; 2(6):15-6.
Evaluation of state comprehensive cancer control plans for genomics content. [Prev Chronic Dis. 2012]
Evaluation of state comprehensive cancer control plans for genomics content.
Laufman JD, Duquette D, Trepanier A. Prev Chronic Dis. 2012 Dec; 9:E176.
Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument. [BMC Med. 2012]
Methodological quality of English-language genetic guidelines on hereditary breast-cancer screening and management: an evaluation using the AGREE instrument.
Simone B, De Feo E, Nicolotti N, Ricciardi W, Boccia S. BMC Med. 2012 Nov 21; 10:143. Epub 2012 Nov 21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer ...
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.
Ann Intern Med. 2005 Sep 6 ;143(5):355-61.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: